INTRODUCTION
============

American tegumentary leishmaniasis (ATL) is a zoonotic disease caused by the protozoan *Leishmania*, which affects both humans and animals. It is an infectious disease with chronic evolution and is classified in several clinical forms: cutaneous, mucosal and mucocutaneous[@B1].

ATL, a neglected disease[@B2], is a public health problem that requires attention and is classified as one of the six infectious diseases of great importance owing to its high detection coefficient and characteristics that cause deformities. Due to the occurrence of lesions, ATL can compromise the patient\'s psychological state, besides affecting social and economic status, as it is also considered an occupational disease[@B3].

Brazil is one of the five main countries with the highest incidences of ATL worldwide[@B4]. The epidemiology of ATL has been continuously changing in recent years, since it was primarily characterized as a zoonosis transmitted to humans when they came into contact with the vectors in forests. However, ATL has also started to emerge in deforested rural and peri-urban areas[@B1]. This situation may be explained by the presence of various vectors, reservoirs and etiological agents, together with socioeconomic and environmental conditions, such as unplanned urbanization, deforestation and population concentration, which can contribute to changes in the disease cycle[@B4].

Amazonas is the Brazilian State with the highest incidence of ATL, with *Leishmania (Viannia) guyanensis* as the etiologic agent. In addition, ATL has recently become widespread with an increased incidence in the State, especially in municipalities previously free of the disease[@B5]. However, there have been few attempts at scientific evaluation in the scientific world, media and general society and as it is a severe disease that can cause suffering and increase economic burden, it calls for the attention of health services[@B6].

It is important to provide information that could be used to manage and control the disease in endemic areas. This is the focus of the epidemiological surveillance, because there is no objective method, such as a vaccine, for preventing this disease. Health education is required to create awareness among populations in order to promote the avoidance of areas with epidemic outbreaks, and for those in areas at risk, to promote the use of preventive strategies, such as repellents, mosquito nets, window and door screens and environmental management to avoid vector contact. Therefore, this study aimed to identify the epidemiological profile of ATL and its spatial and temporal distributions in Amazonas, from 2010 to 2014.

MATERIAL AND METHODS
====================

Study design
------------

This was an epidemiological, observational and ecological study, performed using the ATL data annually reported by the Information System of Notifiable Diseases (SINAN), focusing on epidemiological, spatial and temporal distribution.

Study area
----------

The study area was the entire Amazonas State, the largest State in Brazil, with an area of 1,559,146.876 km^2^ [@B7] but low population density (3,873,743 inhabitants)[@B8], corresponding to 2.5 inhabitants/km^2^ in 2014. However, this State has the highest incidence of ATL, with an average of 50 cases/100,000 inhabitants compared to the 10.4 cases/100,000 inhabitants recorded in the entire country in 2014[@B9].

Study population and data source
--------------------------------

The study population consisted of all newly diagnosed cases of ATL reported to SINAN in Amazonas (Brazilian Amazon), from January 1^st^, 2010, to December 31^st^, 2014.

Annual ATL data from SINAN were obtained from the Ministry of Health, without individual identification (updated on September 21^st^, 2015). Therefore, these were secondary data, and approval from the research ethics committee for studies involving human participants was thus not required, according to the National Health Council, Resolution 510/2016[@B10]. Each row in the database corresponds to a case; the cases were grouped according to municipality for the analysis, as well as in appended databases according to the year of notification.

Annual population estimates were recorded in the Department of Information of Unified Health System (Datasus) and were obtained at the municipal level[@B11].

Variables
---------

The data were analyzed by: 1) demographic profile (sex, age, years of education and ethnicity). The classification of ethnicity or skin color followed the guidelines of the Brazilian Institute of Geography and Statistics (IBGE). People are asked to classify themselves based on their skin color; hence, we adopted the terms Black, Yellow, White, Mixed Ethnicity (Black and White) and Indigenous[@B12]. In this analysis we grouped individuals into mixed ethnicity and not mixed ethnicity groups, since the majority of the population, and consequently, the cases, belonged to this group; 2) clinical aspect, diagnosis, and follow-up (ATL clinical form, HIV-ATL coinfection, and diagnostic exams, such as direct parasitology \[biopsy of the lesion whose material is used to make a smear on a slide, which is then stained with Giemsa\][@B3], Montenegro intradermic reaction, and histopathology); 3) geographical aspects (municipality, urban/rural housing area and epidemiological classification \[autochthonous/imported\]); and 4) ATL burden: annual incidence rate, obtained using the following formula:
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×
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,

000
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Data analysis
-------------

Descriptive statistics were used to summarize the data, presenting the percentage of the annualized distribution of the variables. The incidence rate was stratified into five categories, according to the mean rate from 2010 to 2014 for all municipalities: up to 25; \>25 to \<=50; \>50 to \<=100; \>100 to \<=200; and \>200. These ATL cutoff points followed the exploratory analysis in which a similar interquartile distribution of the rate, in most years, was found. For each category of ATL rate, we obtained the median and quartile in order to understand the evolution of the disease; we have also obtained the median for each year. The median was used since the distribution of the annual rates of ATL was not normal according to the Shapiro-Wilk test. The spatial distribution was calculated by mapping the crude annual incidence rates of ATL in Amazonas (Brazilian Amazon). The spatial results are presented in thematic maps created using Q-Gis^®^ free software, version 2.16.

RESULTS
=======

ATL was predominantly found in men, comprising approximately 80% of all reported cases. It is important to note that the Demographic Census of the IBGE in 2010 registered 1,822,607 (50.6%)[@B8] men in the Amazonas State, which reinforces the magnitude of the higher burden of infection in males. It was also mainly observed in adults between 20 and 40 years old, with mixed ethnicity (black and white) and low educational level. In several cases, schooling data were missing or incomplete ([Table 1](#t1){ref-type="table"}).

###### Distribution of demographic characteristics of new American tegumentary leishmaniasis cases in Amazonas, 2010--2014.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------
  Description                                                 2010\                     2011\        2012\        2013\        2014\        Total cases\   
                                                              n = 1,089\                n = 2,112\   n = 2,077\   n = 1,361\   n = 1,745\   n = 8,384      
                                                              %                         %            %            %            %                           
  ----------------------------------------------------------- ------------------------- ------------ ------------ ------------ ------------ -------------- -------
  **Sex**                                                                                                                                                  

                                                              Male                      81.6         81.3         78.6         78.5         78.5           6,675

                                                              Female                    18.4         18.7         21.4         21.5         21.5           1,709

  **Age group (years)**                                                                                                                                    

                                                              \<1                       1.3          1.0          0.9          1.1          1.7            98

                                                              1 to 14                   14.3         13.0         16.7         16.2         15.5           1,268

                                                              15 to 19                  13.6         12.0         13.7         12.0         14.1           1,097

                                                              20 to 29                  31.5         28.1         25.7         24.7         24.1           2,227

                                                              30 to 39                  20.3         21.4         18.1         21.1         19.7           1,678

                                                              40 to 49                  9.3          14.6         13.0         11.8         12.7           1,019

                                                              50 or more                9.7          11.9         11.9         13.2         12.2           997

  **Years of schooling**                                                                                                                                   

                                                              0 to 8                    58.7         40.4         43.0         41.3         35             3,151

                                                              9 or more                 12.9         10.9         11.0         18.1         14.5           1,508

                                                              Not applicable            5.4          5.1          4.6          5.0          5.0            421

                                                              Ignored/missing data      22.9         43.5         41.3         35.5         45.5           3,304

  **Skin color/ethnicity** [\*](#TFN1){ref-type="table-fn"}                                                                                                

                                                              Mixed (Black and White)   67.9         82.5         82.6         82.1         83.1           6765

                                                              Not mixed/others          32.1         17.5         17.4         17.9         16.9           1619
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------

Source: Information System of Notifiable Diseases (SINAN).

Classification based on the Brazilian Institute of Geography and Statistics, which considered skin color and ethnicity as synonymous.

Regarding the clinical aspects, for all the analyzed years, the proportion of cutaneous ATL was greater than 95%. No records of mixed forms (mucocutaneous) were found. The occurrence of HIV-ATL coinfection was low (\<1% throughout the study period), but HIV tests were not performed in more than half of the cases, except in 2010. Direct parasitological examination was performed in approximately 90% of the cases. Regarding geographical aspects, ATL was found in both rural and urban areas. This clearly indicated that the transmission pattern of the disease was not only wild, but also autochthonous, corresponding to approximately 75--80% of all cases ([Table 2](#t2){ref-type="table"}).

###### Clinical and geographic annual percentage distribution of new American Tegumentary Leishmaniasis cases in Amazonas, 2010--2014.

  ---------------------------------------------------------------------------------------------------------------------------------------------------
  Description                                2010\                         2011\        2012\        2013\        2014\        Total cases\   
                                             n = 1,089\                    n = 2,112\   n = 2,077\   n = 1,361\   n = 1,745\   n = 8,384      
                                             %                             %            %            %            %                           
  ------------------------------------------ ----------------------------- ------------ ------------ ------------ ------------ -------------- -------
  **Clinical form**                                                                                                                           

                                             Cutaneous                     95.9         97.2         96.8         96.6         97.1           8,117

                                             Mucosal                       4.1          2.8          3.2          3.4          2.9            267

  **HIV coinfection**                                                                                                                         

                                             Yes                           0.6          0.4          0.6          0.4          0.6            43

                                             No                            58.0         37.2         43.8         34.4         39.8           3,492

                                             Unknown                       41.4         62.4         55.6         65.2         59.6           4,849

  **Diagnostic exams**                                                                                                                        

  **Direct parasitology**                                                                                                                     

                                             Yes                           86.9         88.5         87.6         89.1         90.5           7,425

                                             No/not performed              13.1         11.5         12.4         10.9         9.5            959

  **MIR** [\*](#TFN2){ref-type="table-fn"}                                                                                                    

                                             Yes                           10.9         5.1          6.6          5.4          4.2            511

                                             No                            1.4          2            2.1          1.6          1.2            143

                                             Not performed                 87.7         92.9         91.3         93.0         94.6           7,730

  **Histopathology**                                                                                                                          

                                             Parasite/compatible finding   9.5          13.3         13.7         13.5         11.3           1,191

                                             Not compatible                4.4          2.8          3.6          2.8          2.7            7,193

                                             Not performed                 86.0         83.9         82.6         83.9         86.0           7,068

  **Zone**                                                                                                                                    

                                             Urban                         52.2         45.6         43.3         48.1         46.0           3,890

                                             Rural                         45.9         50.5         53.5         49.7         51.5           4,253

                                             Periurban                     0.4          0.3          0.2          0.5          0.6            32

                                             Unknown/missing data          1.5          3.6          3.0          1.6          1.9            209

  **Epidemiological classification**                                                                                                          

                                             Autochthonous                 75.5         83.1         82.5         79.6         84.7           6,852

                                             Imported                      24.5         16.9         17.5         20.4         15.3           1,532
  ---------------------------------------------------------------------------------------------------------------------------------------------------

Montenegro Intradermic Reaction.

Source: Information System of Notifiable Diseases (SINAN).

Temporal distribution
---------------------

The temporal distribution showed that ATL incidence increased from 2010 to 2011, remained constant in 2012, decreased during 2012 and 2013, and increased in 2013 and 2014 ([Figure 1](#f1){ref-type="fig"}). In the category \> 200, the median incidence rate has shown oscillations, with an increase in 2011 and reduction in subsequent years, increasing again in 2014. The opposite behavior was observed in the stratum \> 100 to 200, with a pronounced increase in the year 2013. In the other strata, the median incidence rate was similar across all years ([Table 3](#t3){ref-type="table"}).

![Incidence rate per 100,000 inhabitants of American Tegumentary Leishmaniasis, Amazonas, 2010-2014. \*limited to 200 cases per 100,000 inhabitants, considering the incidence rate from 2010 to 2014.](1678-9946-rimtsp-61-S1678-9946201961022-gf01){#f1}

###### Incidence rate of American Tegumentary Leishmaniasis, according to categories of rate and years, Amazonas, 2010--2014.

  Category of rate (interquartile distribution)   2010      2011            2012              2013             2014             
  ----------------------------------------------- --------- --------------- ----------------- ---------------- ---------------- ----------------
  **Up to 25**                                                                                                                  
                                                  Median    6.0             8.3               7.0              5.9              8.1
                                                  (Q1;Q3)   (0;13.8)        (6.0; 16.2)       (0; 17.5)        (0; 14.8)        (3.6; 16.3)
  **\> 25 to 50**                                                                                                               
                                                  Median    36.6            35.5              28.5             35.5             28.4
                                                  (Q1;Q3)   (28.4;46.7)     (31.1; 44.1)      (27.8; 37.5)     (27.1; 44.3)     (26.7; 38.9)
  **\> 50 to 100**                                                                                                              
                                                  Median    69.2            66.2              66.1             63.7             78.0
                                                  (Q1;Q3)   (54.4;76.6)     (54.7; 90.1)      (58.3; 77.0)     (57.0; 79.8)     (64.7; 80.0)
  **\> 100 to 200**                                                                                                             
                                                  Median    138.4           125.5             146.5            164.7            125.5
                                                  (Q1;Q3)   (113.8;142.3)   (104.4; 146.4)    (112.7; 152.2)   (122.5; 195.5)   (116.3; 135.7)
  **\> 200**                                                                                                                    
                                                  Median    440.3           730.5             541.5            454.7            646.3
                                                  (Q1;Q3)   (353.3;527.3)   (228.7; 1032.5)   (206.3; 953.9)   (419.6; 489.7)   (534.1; 758.5)
  **Total**                                                                                                                     
                                                  Median    14.6            41.3              44.5             18.8             25.7
                                                  (Q1;Q3)   (3.8;54.1)      (11.7; 90.1)      (16.4; 86.9)     (3.9; 44.3)      (8.4; 77.7)

Source: Information System of Notifiable Diseases (SINAN).

Spatial distribution
--------------------

In the spatial distribution analysis, the incidence rate was higher in the municipalities neighboring the town of the State capital, Manaus, as well as in the Southern areas of Amazonas. In 2011 and 2012, the disease was widespread in several municipalities ([Figure 2](#f2){ref-type="fig"}).

![Spatial distribution of incidence rate per 100,000 inhabitants of American Tegumentary Leishmaniasis, Amazonas, 2010 to 2014. A) 2010; B) 2011; C) 2012; D) 2013; E) 2014; F) 2010 to 2014.](1678-9946-rimtsp-61-S1678-9946201961022-gf02){#f2}

Next to the capital, the Municipality of Rio Preto da Eva, had the highest incidence rates (\>1,000 cases per 100,000 inhabitants throughout the whole period), followed by Presidente Figueiredo, with an incidence rate of 730 and 872 cases per 100,000 inhabitants in 2011 and 2012, respectively. Epidemic outbreaks have also occurred in other municipalities over the years: Tefe in 2011 (central area of Amazonas) and Caruari and Boca do Acre in 2012 (in the South of Amazonas) ([Figure 2](#f2){ref-type="fig"}).

The following municipalities had the highest incidence per 100,000 inhabitants during the study period: Apui (125, in 2011), Barcelos (139, in 2011), Boca do Acre (202, in 2012), Carauari (210, in 2012), Envira (135, in 2014), Humaita (193, in 2012), Labrea (151, in 2012) and Novo Aripuana (153, in 2012) ([Figure 2](#f2){ref-type="fig"}). Of these, only the Barcelos municipality is not located in the South of Amazonas. Therefore, areas with the highest incidence rates of ATL were the municipalities bordering other states in the South of Amazonas, such as Rondonia, Acre, and Mato Grosso, in which ATL is endemic.

DISCUSSION
==========

The incidence rate of ATL in Amazonas is surprisingly higher than that in other Brazilian States[@B9]. The epidemiological profile of the cases is almost similar to that from studies conducted in Amazonas and other States[@B13] ^--^ [@B15]. However, the age group with the highest prevalence in this study was the one between 20 and 40 years old, which is the most economically productive age group, especially for those who live outside the capital. The occupational profile of ATL is primarily associated with a high incidence of heavy labor activities, such as mining or gold prospecting, farming[@B13] ^,^ [@B16], deforestation for livestock production[@B17] and environmental transformations related to increased rural migration[@B18].

The following are the possible explanations for the increase in reported ATL cases in the capital of Amazonas, Manaus City, as well as in some municipalities in the metropolitan region of Manaus, such as Rio Preto da Eva and Presidente Figueiredo: access to forest and periurban areas, especially for leisure activities; haphazard occupations[@B19] in regions where recent deforestation has occurred; tourism activities and the search for access to health services in the capital, where patients often provide the address of their relatives and acquaintances, and conceal their original addresses, which makes it difficult to report the origin of the cases. Therefore, some individuals may not feel vulnerable to ATL because they live in urban areas or because they lack information about the clinical manifestations, mode of transmission and outcome of the disease, and seek care only when the wound has not healed for some time.

Another aspect responsible for neglected ATL, especially among affected people, is that when an individual has an open wound on the skin, he/she may believe that it will heal by itself in time, and usually skin problems are not a priority and are perceived as aesthetic concerns only[@B20]. This may be an explanation for the persistence of the endemic disease, since the individual may remain infected for a long time without any treatment.

Data from the World Health Organization estimate that Brazil is one of the 10 countries accounting for approximately 87% of cutaneous leishmaniasis cases worldwide (in 2015)[@B2], and our data confirmed the high incidence in Amazonas, with no trend for a decline. This situation calls attention for its potential to lead to severe deformities[@B1], which cannot be neglected. In contrast, it is possible to infer that cutaneous leishmaniasis has been efficiently treated, since the cutaneous form occurred in more than 90% of the reported cases. It is known that the mucosal form only occurs as an ATL complication and further develops into the mucocutaneous form when untreated or neglected[@B20]. Mucosal ATL is more severe than other forms, responds slowly to treatment, and is more susceptible to coinfections. Therefore, early diagnosis through parasitological examination to look for protozoa in supposedly infected tissues is required[@B21] ^,^ [@B22]. One can observe, based on this study\'s results, that the parasitological examination was not performed in all most cases. The lack of parasitological evaluation may prevent early diagnosis and, consequently, compromise proper treatment.

The low proportion of HIV coinfection should also be carefully considered, since the underreporting or lack of specific diagnosis, as evidenced by the high percentage of patients that did not undergo HIV testing may compromise the analysis. ATL progression may be facilitated by HIV coinfection because of decreased immunity. In addition, coinfection demands special ATL treatment; hence, performing an HIV diagnostic test is important, but has been neglected[@B1].

In the past, ATL was considered a rural disease, but is currently evident in urban-rural areas[@B16], which is consistent with this study\'s finding that no differences were found between urban and rural areas. This may be due to environmental changes related to migration, urbanization and socioeconomic aspects, leading to large endemic areas and the emergence of outbreaks. Thus, the vectors of ATL also adapt to new environments, approaching the peridomicile, i.e., around dwellings, facilitating disease transmission even in urban areas[@B18].

The municipality of residence as the probable infection site, in most situation may suggest the population\'s migration to periurban areas or even deforestation within the urban areas, which favors contact with vectors; however, the question arises whether the epidemiological investigation, by the surveillance service, is accurate enough to identify the patient\'s trips to probable sites of infection in an area distant from his or her home. In turn, autochthony facilitates tracking down and effectively diagnosing ATL cases, even in more isolated municipalities.

Although there is expansion in the spatial distribution and an increase in the incidence of ATL in Amazonas, the epidemiological profile has remained similar across the years, suggesting that other factors must be responsible for the increasing spatial and temporal distribution of the disease. Therefore, strategic actions should be implemented in municipalities that have been identified as endemic, in areas that have experienced epidemic outbreaks over the years and in individuals living in risk areas. Therefore, the results presented in this study may guide health institutions or personnel in the formulation of priorities regarding more vulnerable areas and populations. Finally, continuous research should be conducted to detect possible changes in the epidemiological pattern of ATL to support prevention and control strategies.
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